NCT04359836RecruitingAccepts Healthy Volunteers

A Study to Explore the Role of Gut Flora in COVID-19 Infection

ProgenaBiome

Start Date

4/16/2020

Completion Date

7/31/2027

Summary

This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.

Detailed Description

In this study the stool of patients who are being treated for COVID-19 will be tested during treatment and then again following treatment to determine if the virus is shed in the stool during infection, afterwards, or both.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study 2. Male or female of 18 years of age or older 3. Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening Exclusion Criteria: 1. Refusal to sign informed consent form 2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy. 3. Postoperative stoma, ostomy, or ileoanal pouch 4. Treatment with total parenteral nutrition

Interventions

OTHER

There is no intervention in this study

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Gut MicrobiomeGastrointestinal MicrobiomeCOVIDCOVID-19Corona Virus InfectionCoronavirusCoronaviridae InfectionsCoronavirus 19Coronavirus-19COVID 19

Locations

ProgenaBiome

Ventura, California 93003

United States